Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Phase of Trial: Phase III
Latest Information Update: 23 May 2017
At a glance
- Drugs Iodine-131 (Primary) ; Thyrotropin alfa (Primary) ; Levothyroxine sodium
- Indications Thyroid cancer
- Focus Therapeutic Use
- Acronyms ESTIMABL2
- 15 May 2017 Planned number of patients changed from 750 to 780.
- 15 May 2017 Planned End Date changed from 1 Oct 2020 to 1 Apr 2022.
- 15 May 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Apr 2020.